Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Descriptive epidemiology of physical activity rates in multiple sclerosis.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Inhibition of hyaluronan (HA) synthesis protects against CNS autoimmunity and increases CXCL12 expression in the inflamed CNS.
Gavin Giovannoni on why time matters in multiple sclerosis.
Reciprocal communication between the nervous and immune systems: crosstalk, back-talk and motivational speeches.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
[EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN ADULT RATS AFTER ADMINISTRATION OF INTERLEUKIN-1beta DURING DIFFERENT PERIODS OF EARLY LIFE].
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
Characterization of a eukaryotic-like protein kinase, DspB, with an atypical catalytic loop motif from Myxococcus xanthus.
Regulation of Immunity by Butyrophilins.
Reliability and Repeatability of the Hoffmann Sign.
Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS.
Neurological and functional recovery in acute transverse myelitis patients with inpatient rehabilitation and magnetic resonance imaging correlates.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
Psychological and Neurobehavioral Disorders in MSA Health-Oriented, Rehabilitative Perspective.
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis.
Auditory function in children with Charcot-Marie-Tooth disease.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Progressive multifocal leukoencephalopathy in an immunocompetent patient?
Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
Acute neuronal apoptosis in a rat model of multiple sclerosis.

Pages